Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Nov 17;17(11):e0271988. doi: 10.1371/journal.pone.0271988

Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays

Marcellin N Nouaman 1,2,*, Valentine Becquet 3,4, Mélanie Plazy 5, Patrick A Coffie 1,6, Clémence Zébago 7, Alice Montoyo 8, Camille Anoma 9, Serge Eholié 1,6, François Dabis 5, Joseph Larmarange 4; for the ANRS 12361 PrEP-CI Study group
Editor: Hamid Sharifi10
PMCID: PMC9671321  PMID: 36395099

Abstract

Background

This study aimed to estimate, using an HIV Recent Infection Testing Algorithm (RITA), the HIV incidence and its associated factors among female sex workers (FSW) in Côte d’Ivoire.

Methods

A cross-sectional study was conducted in 2016–2017 in Abidjan and San Pedro’s region among FSW aged ≥ 18 years. In addition, a sociodemographic questionnaire, HIV screening was carried out by two rapid tests. In the event of a positive result, a dried blood spot sample was taken to determine, using a RITA adapted to the Ivorian context, if it was a recent HIV infection.

Results

A total of 1000 FSW were surveyed with a median age of 25 years (interquartile range: 21–29 years). 39 (3.9%) tested positive for HIV. The incidence of HIV was estimated to be 2.3 per 100 person-years, with higher incidence rates among those 24 years old or less (3.0% vs. 1.9%), non-Ivorian FSW (3.2% vs. 1.9%) and those with the lowest education level (4.6% in FSW who never went to school vs. 2.6%). The incidence seemed to be associated with the sex work practice conditions: higher incidence among FSW whose usual price was less than 3.50$ (4.3% vs.1.0%), FSW who had a larger number of clients on the last day of work (6.1% in those with 7 clients or more vs. 1.8%), FSW who reported not always using condoms with their clients (8.5% vs. 1.5%) and FSW who reported agreeing to sex without a condom in exchange for a large sum of money (10.1% vs. 1.2%).

Conclusion

This study confirms that FSW remain highly exposed to HIV infection. Exposure to HIV is also clearly associated with certain sex-work factors and the material conditions of sex work. Efforts in the fight against HIV infection must be intensified to reduce new infections among FSW.

Introduction

Antiretroviral therapy (ART) decreases HIV-related morbidity and mortality as well as infectiousness, resulting in a significant reduction in the risk of HIV transmission from a treated infected person to an uninfected sexual partner [1, 2]. However, while HIV care and treatment programmes have provided access to ART for an estimated 26 million people as of 2020 worldwide, ART coverage is still far from optimal, especially in most resource-limited countries, where the HIV incidence remains relatively high. In particular, Sub-Saharan Africa is disproportionately affected by the HIV epidemic and accounts for almost 70% of HIV infections worldwide. Although new infections have been reduced by 52% since the peak in 1997, 1.7 million people had been newly infected with HIV by the end of 2019 in this region [3, 4].

Key populations and their sexual partners are at particularly high risk of HIV; in 2020, they accounted for 65% of new HIV infections worldwide. Men who have sex with men (MSM) and female sex workers (FSW) are, 25 and 26 times more likely to be infected with HIV respectively, than the general population [3]. Although the high prevalence suggests a high incidence, incidence surveys remain necessary to better understand the dynamics of the epidemic among key populations. While some data are available for MSM [5, 6], few recent incidence surveys have been conducted among FSW [7].

Moreover, HIV incidence is likely to be heterogeneous among subgroups of FSW, depending on local context, type of sex work and whether or not they attend community clinics offering various services, including HIV testing, condom distribution and prevention programmes targeting risky behaviour [8]. With the implementation of large-scale combination prevention strategies, accurate tools to monitor where and among whom new HIV infections are occurring are essential to assess the impact of these strategies and improve the effectiveness of targeted prevention programs [913]. In particular, new prevention tools such as pre-exposure prophylaxis are recommended by the World Health Organization (WHO) for only populations with a substantial risk of infection [14].

Therefore, it is crucial to assess the incidence of HIV infections among FSW. There are several approaches to measure the occurrence of new HIV infections in a population. The gold standard is a prospective cohorts study that analyses HIV seroconversions in uninfected individuals. However, such cohorts studies are very costly and complex to conduct. This is why the most common approach in developing countries has been inference, considering trends in HIV prevalence and assumptions about mortality and the impact of ART coverage on survival [1518]. Recently, several laboratory approaches have been developed to distinguish newly acquired HIV infections from long-term HIV infections in cross-sectional surveys [1921]. These incident HIV detection approaches are based on the principle that the immunological response to HIV infection evolves over several months after infection, allowing the identification of immunological biomarkers of early HIV disease that can serve as indicators of recent infection [22]. The assay-based approach involves the use of one or more serological laboratory tests that is able to classify HIV infection according to whether the infection was acquired in the recent past. Classification using one or more assays of this kind represents an HIV Recent Infection Testing Algorithm (RITA). If accurate, incidence testing can be a rapid and cost-effective approach to obtaining reliable and up-to date information about the dynamics of HIV transmission for more effective planning [23].

An HIV RITA has been developed and adapted to the Ivorian context [24]. The present paper used this HIV RITA to estimate the HIV incidence and its associated factors among FSW in two regions of Côte d’Ivoire: Abidjan and San Pedro.

Methods

Study setting

The ANRS 12361 PrEP-CI cross-sectional study was designed and implemented by two Ivorian community-based organisations between September 2016 and March 2017 [25]. Aprosam works within the city of San Pedro and its surrounding areas, particularly in villages associated with farming businesses (coffee and cocoa production). Espace Confiance operates in several districts of Abidjan, the economic capital of Côte d’Ivoire (Koumassi, Marcory, Treichville, Zone 4 and Port-Bouët including its beaches). These nongovernmental organisations (NGOs) provide HIV prevention and testing services directly at prostitution sites (outreach activities) and provide HIV and sexual health care services for FSW through community clinics. Recruitment of participants for this study was made possible by the Aprosam and Espace Confiance organisations’ networks of peer educators and their access to the target population.

Study population

The study’s purpose was not to represent all FSW in Côte d’Ivoire but rather to represent FSW who could be reached by the two partner organisations and who would potentially benefit from PrEP in a future programme. FSW are identified by the peer educator and they work at sites that are usually visited by them for HIV prevention/screening. Almost all of the FSW work sites were visited by the peer educator. The FSWs were recruited both in prostitution sites (brothel, hotel, bar/maquis, street, beach) and in the fixed clinics dedicated to sex workers of both NGOs.

The survey was conducted among FSW aged 18 years and older, who had never been tested for HIV or who had previously tested negative for HIV, and who worked at a sex work site at the time of the survey, in the areas targeted by the two community-based NGOs.

Sociodemographic and behavioural questionnaire

After obtaining informed written consent, a standardised questionnaire was administered by peer educators. The questionnaire collected sociodemographic data (date of birth, nationality, place of recruitment, level of education), as well as sexual practices and behaviours (such as the duration of sex work, the age at which sex work began, the place of meeting and activity with clients, whether sex work was carried out regularly, the use of condoms during sex work, the price of the pass (the price of a single sexual encounter with a client), the number of clients, the number of condoms used on the last day of activity and the number of sexual intercourse encounters for which a condom was not used during the last seven days).

HIV screening and laboratory analysis

HIV screening was carried out by two rapid tests (Determine®, Alere and Vikia®, bioMérieux), for all surveyed FSWs, at the sex work sites. In the event of a positive result, HIV infection was confirmed by a rapid test (stat-pack®). Then, a dried blood spot (DBS) sample was taken and transported to the laboratory of the University Hospital of Tours, France, to determine the window of infection and false positive rate using a recent infection test adapted to the Ivorian context [24] and performed directly on plasma. This recent infection test made it possible to classify HIV infections into two groups: HIV infections contracted less than 6 months prior and those contracted more than 6 months prior [24]. This recent infection test developed by Barin et al. is the Less-sensitive enzyme Immunodominant assay recent infection (EIA-RI/IDE-V3). This assay uses the enzyme immunoassay technique in a 96-well plate, based on the measurement of absorbances (OD) in one well sensitised with an equimolar peptide mixture TM (cons+D), corresponding to the immunodominant epitope of gp41 (consensus sequence envi—1 group M and consensus sequence env—1 subtype D), and in another well, sensitised with a V3 peptide solution (AE), corresponding to an equimolar mixture of the consensus sequences of the V3 region of gp120 of the HIV subtypes A, B, C, D and CRF01_AE. This test is an in-house test, applicable in the HIV-NRC virology laboratory, serology sector. The test can be performed on serum or plasma, as well as serum, plasma or whole blood on blotting paper or DBS. The test uses a mathematical formula that combines the quantitative responses to gp41 antigens in each region to distinguish between recent and established infection [24].

This in-house test has been the subject of preliminary studies using sequential serum samples from HIV-infected Ivorian patients with known dates of infection (the PRECO-CI ANRS 12277 and PRIMO-CI ANRS 1220 projects) and samples from patients at different stages of the disease (the Temprano ANRS 12136 and Trivacan ANRS 1269 trials); which allowed to distinguish a recent infection (≤180 days) from an established infection (>180 days) with a window of infection (0.3 years) and false positive rate (13‰) for the Ivorian population studied.

During the study, FSW diagnosed with HIV infection were referred to community clinics by peer educators for ART.

Description of the surveyed population

Sociodemographic characteristics and sexual practices and behaviours of the surveyed participants were described according to the study setting (San Pedro or Abidjan). Since the sample was not a random sample but rather a convenience sample of women reached by the two organisations, statistical tests such as Pearson’s χ2 test or Fisher’s exact test could not be formally used to compare differences between the populations from the two study settings. We excluded any missing data from the percentage calculations. All analyses were performed with R version R-4.2.1 software.

Assessment of HIV incidence

For a given population and HIV subtype, a RITA has a mean RITA duration ω, defined as the mean duration for which newly infected individuals in the population have had a recently acquired infection. A RITA also has a false recent rate (FRR), noted as ε, which is the proportion of non recent HIV infections in the population that are misclassified by the RITA as recent.

A RITA is used to estimate HIV infection by first classifying cases of HIV infection in the population as recently acquired or not, and then applying a mathematical formula to the resulting counts of recently acquired infections. The annual incidence rate Ir, is estimated using the following formula:

Ir=R-εP(1-ε)ωN

where N is the number of HIV-negative persons in the survey, P the number of HIV-positive persons, R is the number of persons classified as positive by the RITA, ω is the mean RITA duration in years and ε is the FRR of the RITA [26]. Sweeting et al., in 2010 describe this mathematical approach in more detail [27].

Regarding the RITA used in this study [24], the mean RITA duration (ω) was 0.3 years and the FRR of the RITA (ε) was 0.013.

Factors associated with HIV incidence

HIV incidence rate and their CIs were computed for the different subgroups. Unfortunately, no comparison test or multivariate analysis is currently available for RITA data.

Ethical aspects

All FSW were informed of the risks and benefits of participating in this study before inclusion. All FSW provided written informed consent. The National Ethics Committee for Life Sciences and Health of Côte d’Ivoire approved the research protocol (N/Ref: 057/MSHP/CNER-kp of 28 June 2016).

For ethical reasons, the full survey dataset is available only upon reasonable request at https://zenodo.org/record/5948841. An analytical dataset containing only the variables required to replicate the analysis, as well as the corresponding R script, are available in S1 Data.

Inclusivity in global research

Additional information regarding the ethical, cultural, and scientific considerations specific to inclusivity in global research is included in the Supporting Information.

Results

Sociodemographic and behavioural characteristics

A total of 1000 FSW, including 400 in San Pedro and 600 in Abidjan, were surveyed. The main characteristics of the surveyed population are presented in Table 1. The median age was 25 years (interquartile range: 21–29 years). The FSW surveyed in San Pedro had a lower education level than the FSW surveyed in Abidjan. The FSW in Abidjan engaged in more sex work activity than those in San Pedro. There are differences in socio-demographic characteristics between the two cities. Indeed, Abidjan is the economic capital of the country, in full expansion compared to San Pedro where the level of poverty, literacy or education is lower. San Pedro was in the recent past the largest slum in West Africa and most of the FSWs sites are within the perimeters of this slum.

Table 1. Sociodemographic and behavioural characteristics of the surveyed FSW, ANRS 12361 PrEP-CI study, September 2016—March 2017.

Characteristic, n (%) San Pedro Abidjan Total
n = 400 n = 600 n = 1000
Age in years
24 years or less 163 (41.3) 280 (50.3) 443 (46.5)
 25 years or more 232 (58.7) 277 (49.7) 509 (53.5)
 not documented 5 43 48
Highest level of education
 never been to school 115 (28.9) 105 (17.6) 220 (22.1)
 primary 163 (41.0) 219 (36.7) 382 (38.4)
 secondary / university 120 (30.2) 273 (45.7) 393 (39.5)
 not documented 2 3 5
Nationality
 Ivorian 312 (78.0) 378 (63.0) 690 (69.0)
 other nationality 88 (22.0) 222 (37.0) 310 (31.0)
How many years sex work has been practised
 3 years or less 250 (63.6) 381 (63.8) 631 (63.7)
 4 years or more 143 (36.4) 216 (36.2) 359 (36.3)
 not documented 7 3 10
Usual price with clients
 1999 CFA (~3 €) or less 285 (71.2) 109 (18.2) 394 (39.5)
 2000 CFA (~ 3 €) or more 115(28.7) 489 (81.8) 604 (60.5)
 not documented 0 2 2
Recruitment site
 bar / “maquis” 135 (33.8) 254 (42.3) 389 (38.9)
 brothel 111 (27.8) 142 (23.7) 253 (25.3)
 hotel 101 (25.2) 58 (9.7) 159 (15.9)
 street 15 (3.8) 48 (8.0) 63 (6.3)
 other 38 (9.5) 98 (16.3) 136 (13.6)
Number of clients during last day of sex work
 1 client 21 (5.2) 154 (25.8) 175 (17.6)
 2 to 6 clients 316 (79.0) 394 (66.0) 710 (71.2)
 7 clients or more 63 (15.8) 49 (8.2) 112 (11.2)
 not documented 0 3 3
Condom use with clients
 never / sometimes / often 78 (20.4) 46 (7.9) 124 (12.9)
 always 304 (79.6) 533 (92.1) 837 (87.1)
 not documented 18 21 39
Acceptance of condomless sexual intercourse in exchange for a large sum of money
 never 251 (69.0) 513 (88.0) 764 (80.7)
 Sometimes 52 (14.3) 27 (4.6) 79 (8.3)
 often / always 61 (16.8) 43 (7.4) 104 (11.0)
 not documented 36 17 53
Self-reported STI in the last 12 months,
 none 79 (20.2) 262 (44.5) 341 (34.8)
 yes, at least one 312 (79.8) 327 (55.5) 639 (65.2)
 not documented 9 11 20
Practised sex work in more than one city
 no, 1 city only 200 (50.3) 527 (88.3) 727 (73.1)
 yes, 2 cities or more 198 (49.7) 70 (11.7) 268 (26.9)
 not documented 2 3 5
Last medical visit with a doctor or a nurse
 less than a year 303 (76.1) 367 (61.4) 670 (67.3)
 more than a year or never consulted 95 (23.9) 231 (38.6) 326 (32.7)
 not documented 2 2 4

STI: sexually transmitted infection

Incidence of HIV infection

Among the surveyed FSW (those never tested or with a previous negative test result), 39 (3.9%) tested positive for HIV (6.3% in San Pedro and 2.3% in Abidjan) during the survey. Of these, seven FSW were classified as being recently infected according to the RITA (average duration of infection 113 days or 0.3 years).

The incidence of HIV was estimated to be 2.3 per 100 person-years overall (Table 2), with 3.3% in San Pedro and 1.6% in Abidjan.

Table 2. Estimated HIV incidence by HIV exposure factors among FSW, ANRS 12361 PrEP-CI study, September 2016 –March 2017.

R P N Estimated incidence per 100 person-years
Overall population 7 39 961 2.3
Region
 San Pedro 4 25 375 3.3
 Abidjan 3 14 586 1.6
Age group
 24 years or less 4 16 427 3.0
 25 years or more 3 22 487 1.9
Highest level of education
 never been to school 3 13 207 4.6
 primary 3 17 365 2.6
 secondary / university 1 09 384 0.8
Nationality
 Ivoirian 4 26 664 1.9
 other nationality 3 13 297 3.2
How many years sex work has been practised
 3 years or less 4 20 611 2.1
 4 years or more 3 19 340 2.7
Usual price with clients
 1999 CFA (~3 €) or less 5 24 370 4.3
 2000 CFA (~3 €) or more 2 15 589 1.0
Recruitment site
 bar/“maquis” 1 9 380 0.8
 brothel 3 16 237 4.0
 hotel 2 9 150 4.2
 street 1 2 61 5.4
 other 0 3 133 0.0
Number of clients during last day of sex work
 1 client 1 5 170 1.9
 2 to 6 clients 4 27 683 1.8
 7 clients or more 2 7 105 6.1
Condom use with clients
 never / sometimes / often 3 9 115 8.5
 always 4 29 808 1.5
Acceptance of condomless sexual intercourse in exchange for a large sum of money
 never 3 24 740 1.2
 sometimes 1 7 72 4.3
 often / always 3 7 97 10.1
Self-reported STI in the last 12 months
 none 2 8 333 1.9
 yes, at least one 5 30 609 2.6
Practised sex work in more than one city
 no, 1 city only 4 22 705 1.8
 yes, 2 cities or more 3 17 251 3.7
Last medical visit with a doctor or a nurse
 less than a year 3 22 648 1.4
 more than a year or never consulted 4 17 309 4.1

R: number of persons classified as RITA positive; P: number of HIV-positive persons; N: number of HIV-negative persons in the survey. Mean RITA duration (ω) of 0.3 years. False recent rate of the RITA (ε) of 0.13. STI: sexually transmitted infection.

Associated factors

Some trends emerged from the results presented in Table 2.

There were variations according to the sociodemographic characteristics of the participants, with higher incidence rates among the youngest age group (3.0% in FSW 24 years old or less vs. 1.9% in FSW 25 years old or more), non-Ivorian FSW (3.2% in non-Ivorian FSW vs. 1.9% in Ivoirian FSW) and the group with the lowest education level (4.6% in FSW who never went to school vs. 2.6% in those with a primary education level and 0.8% in those with a secondary or university education level).

The incidence of HIV also seemed to be associated with the sex work practice conditions. Indeed, FSW who charged a lower price for sexual intercourse had a higher HIV exposure rate (4.3% in FSW whose usual price was less than 3.5$ vs. 1.0% in FSW whose usual price was more than 3.5$). In addition, FSW working in brothels (4.0%), in the streets (5.4%), and in hotels (4.2%) were more likely to be recently infected than those working in bars or “maquis” (0.8%). The incidence was higher among FSW who had a larger number of clients on the last day of work (6.1% in those with 7 clients or more vs. 1.8% in those with 2–6 clients) and who worked in more than one city (3.7% vs. 1.8%). The incidence did not seem to differ according to tenure in the sex industry (2.7% in FSW who performed sex work for 3 years or more vs. 2.0% in FSW who performed sex work for 3 years or less).

A higher incidence was observed among FSW who reported not always using condoms when engaging with their clients (8.5% vs. 1.5%); who reported agreeing to sex without a condom in exchange for a large sum of money (10.1% vs. 1.2); who reported contracting a sexually transmitted infection (STI) in the last 12 months (2.6% vs. 1.9%); and who had consulted a health professional more than one year previously (4.1% vs. 1.4%).

Discussion

Our results confirm that FSW remain at high risk of exposure to HIV population in Côte d’Ivoire, with an estimated overall incidence of 2.3% (1.6% in Abidjan and 3.2% in the San Pedro region). In Côte d’Ivoire, the HIV incidence among women in the general population aged 15–64 years was estimated to be 0.03%. Specifically, it was 0.04% among women aged 15–24 years and 0.05% among those aged 25–34 years, according to the Côte d’Ivoire Population-Based HIV Impact Assessments (CIPHIA) 2017–2018 survey [28].

Our results in FSW in Côte d’Ivoire are higher than those estimated in China by Wang et al. in 2012 and in Cotonou, Benin by Diabaté et al. in 2018, who reported rates of 1.4% and 1.4%, respectively [29, 30]. On the other hand, our result was lower than 3.5% estimated by Braunstein et al. in 2011 among FSW in Rwanda [31].

Our results are consistent with well-documented risk factors associated with HIV in previous studies [29, 31, 32]. The HIV incidence was higher among those who reported having contracted an STI in the past 12 months, those who reported not always using a condom when engaging in sex work, and those who admitted to agreeing to sex without a condom in exchange for a large sum of money than among their counterparts. This high incidence of HIV infection further evidences this among FSWs in San Pedro compared to those practising in Abidjan. In fact, they charged a lower pass price with a higher number of customers. They also had a lower rate of condom use and were more likely to accept sex without condoms in exchange for a large sum of money, and they reported more STIs than those in Abidjan. All these factors favour exposure to HIV infection.

Our results also highlight that the working conditions of FSW effect the risk of HIV exposure and acquisition. Women working in brothels, hotels or on the street had higher exposure rates than those working in bars and “maquis”. It should be noted that sex work associated with bars/“maquis” are usually occasional; therefore, these FSW generally have fewer clients. A large number of clients on the last day of work was also associated with HIV acquisition. Thus, a larger number of clients increases the risk of HIV infection [29, 32].

Generally, a link between precariousness and HIV acquisition was demonstrated in our results. We observed higher incidences among less-educated FSW, younger FSM, FSW who charged a lower price for sex, FSW of foreign nationality (most often with greater social and administrative insecurity), and FSW who practised sex work in multiple cities than among their counterparts. Similarly, those who are located farther from health services have a higher risk, as the incidence was higher among those who reported not having consulted a health professional in the twelve months preceding the survey. These results corroborate the work of Szwarcwald et al. in 2018 and of Muldoon et al. in 2015 [33, 34].

We hypothesised before the survey that those who had recently entered the sex work market would be at higher risk because they have less knowledge about prevention and less capacity to negotiate condom use, but we did not observe any differences in exposure data according to the length of time they had been practising sex work. On the one hand, foreign FSW who are new to the country are usually supervised and educated by site managers about the need for systematic condom use. On the other hand, analysis of the questionnaires and qualitative interviews, which were conducted as part of the same survey and previously published [25], highlighted that despite a high rate of condom use and strong negotiation skills, FSW remain have a high HIV and other STIs exposure rate, as some sexual intercourses events do not involve the use of condoms. FSW’ responses to the question assessing condom use might refer to ‘typical use’ as opposed to specific circumstances [25]. Also the difference between reported STI cases and the proportion of condom use could be the effect of temporality. Indeed, STIs were reported in the last 12 months while responses on condom use during sex were related to current use, in the week or month before the survey. Also, FSW have difficulty negotiating condom use with their boyfriends or husbands, even when they do not know their HIV status and engage in sex with multiple sexual partners. They also willingly accept condomless sex with some regular clients whom they feel they can trust or when they are in high need of money.

Our study is one of the first to estimate the incidence of HIV in FSW in Côte d’Ivoire using tests to detect recent infection. Incidence data from at-risk populations are key in designing better programmes and interventions to limit new infections. Recent infection surveillance is a powerful tool with which Cote d’Ivoire’s national HIV/AIDS program may identify geographic areas and demographic groups within which HIV transmission is ongoing. More broadly, similar explorations would lend important insight into transmission dynamics in a high-stigma environment. Another strength of this study is the recruitment, through peer educators, of FSW with diverse profiles from different locations.

Yet, we have to acknowledge some limitations. First, as RITA is a biological assay, classification of infections as recent or not does not rely on self-reported information. Some people with long-standing HIV infection and on treatement may be misclassified as newly infected. However, these false recent cases are taken into account, as a false recent rate is applied when estimating incidence. Secondly, our data suffer from a lack of power due to a relative sample size with a few number of FSW recently HIV-infected. In addition, the comparison between San Pedro and Abidjan could not been done with statistical tests because the sample was not a random sample but rather a convenience sample. Also, our data came from a convenience sample. It was not appropriate to present the confidence intervals. We were not able to perform a multivariate analysis. Some of the observed associations may result from interactions between several variables. For example, more foreign FSW than Ivorian FSW work in brothels, resulting in foreign FSW having larger numbers of clients.

Conclusion

Although community-based prevention programmes for sex workers have led to the empowerment of FSW and a high rate of male condom use in general, they are not sufficient on their own to completely eliminate the risks of HIV acquisition. This study confirms that FSW, even those who have engaged in sex work for several years, remain highly exposed to HIV infection. Exposure to HIV is also clearly associated with certain sex-work factors and the material conditions of sex work.

Efforts in the fight against HIV infection must be intensified to reduce new infections among FSW. There is a need for appropriate people-centred prevention programmes that include new prevention tools, such as pre-exposure prophylaxis, and take into account the living and working conditions of FSW.

Supporting information

S1 Data

(ZIP)

Acknowledgments

We would like to thank all participants as well as Aprosam’s and Espace Confiance’s peer educators and the ANRS 12361 PrEP-CI study group: Aboubakar Sangaré (Aprosam, San Pedro, Côte d’Ivoire), Anglaret Xavier (PAC-CI, Abidjan, Côte d’Ivoire / Inserm, Bordeaux, France), Anoma Camille (Espace Confiance, Abidjan, Côte d’Ivoire), Barin Francis (Université François Rabelais, Tours, France), Bazin Brigitte (ANRS, Paris, France), Becquet Valentine (Ceped/IRD, Paris, France), Dabis François (ISPED/Inserm, Bordeaux, France), Danel Christine (PAC-CI, Abidjan, Côte d’Ivoire / Inserm, Bordeaux, France), Eholie Serge (PAC-CI, Abidjan, Côte d’Ivoire), Ekouevi Didier (PAC-CI, Abidjan, Côte d’Ivoire), Fonsart Julien (Hôpital SaintLouis, Paris, France), Gbosi Kate (Aprosam, San Pedro, Côte d’Ivoire), Kwamé Abo (Programme National de Lutte contre le Sida, Côte d’Ivoire), Larmarange Joseph (Ceped/IRD, Paris, France), Masumbuko Jean-Marie (PAC-CI, Abidjan, Côte d’Ivoire), Méda Nicolas (Centre Muraz, Bobo-Dioulasso, Burkina Faso), Moh Raoul (PAC-CI, Abidjan, Côte d’Ivoire), Molina Jean-Michel (Hôpital Saint-Louis, Paris, France), N’dri-Yoman Thérèse (PAC-CI, Abidjan, Côte d’Ivoire), Nouaman Marcellin (PAC-CI, Abidjan, Côte d’Ivoire), Plazy Mélanie (ISPED / Inserm, Bordeaux, France), Soh Kouamé (Aprosam, San Pedro, Côte d’Ivoire), Tanoe Solange (Espace Confiance, Abidjan, Côte d’Ivoire), Yeo Roselyne (Espace Confiance, Abidjan, Côte d’Ivoire).

Data Availability

For ethical reasons, the full survey dataset is available only upon reasonable request at https://zenodo.org/record/5948841. An analytical dataset containing only the variables required to replicate the analysis, as well as the corresponding R script, are available in Supplementary material.

Funding Statement

The PrEP-CI ANRS 12361 was funded by the Bill and Melinda Gates Foundation (Investment ID: OPP1106343) and the French National Agency for AIDS and Viral Hepatitis Research (ANRS). https://www.gatesfoundation.org/ The Bill & Melinda Gates Foundation aims to reduce inequities in health by developing new tools and strategies to reduce the burden of infectious disease.

References

  • 1.Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou S-S, Zhang XC, et al. Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial. J Acquir Immune Defic Syndr 1999 2017; 74:112–116. doi: 10.1097/QAI.0000000000001158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med 2016; 375:830–839. doi: 10.1056/NEJMoa1600693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Global HIV & AIDS statistics—Fact sheet. https://www.unaids.org/en/resources/fact-sheet (accessed 2 Nov2021).
  • 4.AIDS by the numbers 2015. https://www.unaids.org/sites/default/files/media_asset/AIDS_by_the_numbers_2015_en.pdf.
  • 5.Kimani M, van der Elst EM, Chiro O, Oduor C, Wahome E, Kazungu W, et al. PrEP interest and HIV‐1 incidence among MSM and transgender women in coastal Kenya. J Int AIDS Soc 2019; 22:e25323. doi: 10.1002/jia2.25323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lane T, Osmand T, Marr A, Struthers H, McIntyre JA, Shade SB. Brief Report: High HIV Incidence in a South African Community of Men Who Have Sex With Men: Results From the Mpumalanga Men’s Study, 2012–2015. J Acquir Immune Defic Syndr 1999 2016; 73:609–611. [DOI] [PubMed] [Google Scholar]
  • 7.Djomand G, Quaye S, Sullivan PS. HIV epidemic among key populations in west Africa. Curr Opin HIV AIDS 2014; 9:506–513. doi: 10.1097/COH.0000000000000090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nagot N, Ouangré A, Ouedraogo A, Cartoux M, Huygens P, Defer MC, et al. Spectrum of Commercial Sex Activity in Burkina Faso: Classification Model and Risk of Exposure to HIV. JAIDS J Acquir Immune Defic Syndr 2002; 29:517–521. doi: 10.1097/00126334-200204150-00013 [DOI] [PubMed] [Google Scholar]
  • 9.Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298. doi: 10.1371/journal.pmed.0020298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493–505. doi: 10.1056/NEJMoa1105243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet Lond Engl 2007; 369:643–656. doi: 10.1016/S0140-6736(07)60312-2 [DOI] [PubMed] [Google Scholar]
  • 12.Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet Lond Engl 2007; 369:657–666. doi: 10.1016/S0140-6736(07)60313-4 [DOI] [PubMed] [Google Scholar]
  • 13.Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization’s global antiretroviral guidance. J Int AIDS Soc 2013; 16:18757. doi: 10.7448/IAS.16.1.18757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: World Health Organization; 2015. http://www.ncbi.nlm.nih.gov/books/NBK327115/ (accessed 19 Dec2021). [PubMed]
  • 15.Gouws E, White PJ, Stover J, Brown T. Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sex Transm Infect 2006; 82 Suppl 3:iii51–55. doi: 10.1136/sti.2006.020164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hallett TB, Zaba B, Todd J, Lopman B, Mwita W, Biraro S, et al. Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med 2008; 5:e80. doi: 10.1371/journal.pmed.0050080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, et al. Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PloS One 2011; 6:e17535. doi: 10.1371/journal.pone.0017535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Stover J, Walker N, Grassly NC, Marston M. Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sex Transm Infect 2006; 82 Suppl 3:iii45–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Le Vu S, Pillonel J, Semaille C, Bernillon P, Le Strat Y, Meyer L, et al. Principles and uses of HIV incidence estimation from recent infection testing—a review. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 2008; 13:18969. [PubMed] [Google Scholar]
  • 20.Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 2008; 13:18966. [PubMed] [Google Scholar]
  • 21.Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, et al. Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. J HIV AIDS Surveill Epidemiol 2010; 2:1–14. [PMC free article] [PubMed] [Google Scholar]
  • 22.Kim AA, Parekh BS, Umuro M, Galgalo T, Bunnell R, Makokha E, et al. Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based Survey. PLoS ONE 2016; 11. doi: 10.1371/journal.pone.0155498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Incidence Assay Critical Path Working Group. More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med 2011; 8:e1001045. doi: 10.1371/journal.pmed.1001045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Barin F, Meyer L, Lancar R, Deveau C, Gharib M, Laporte A, et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol 2005; 43:4441–4447. doi: 10.1128/JCM.43.9.4441-4447.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Becquet V, Nouaman M, Plazy M, Masumbuko J-M, Anoma C, Kouame S, et al. Sexual health needs of female sex workers in Côte d’Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention. BMJ Open 2020; 10:e028508. doi: 10.1136/bmjopen-2018-028508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.World Health Organization, editor. When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva, Switzerland: World Health Organization; 2011. [Google Scholar]
  • 27.Sweeting MJ, De Angelis D, Parry J, Suligoi B. Estimating the distribution of the window period for recent HIV infections: a comparison of statistical methods. Stat Med 2010; 29:3194–3202. doi: 10.1002/sim.3941 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.CIPHIA-Final-Report_Fr.pdf. https://phia.icap.columbia.edu/wp-content/uploads/2021/05/CIPHIA-Final-Report_Fr.pdf (accessed 30 Sep2021).
  • 29.Wang H, Reilly KH, Brown K, Jin X, Xu J, Ding G, et al. HIV incidence and associated risk factors among female sex workers in a high HIV-prevalence area of China. Sex Transm Dis 2012; 39:835–841. doi: 10.1097/OLQ.0b013e318266b241 [DOI] [PubMed] [Google Scholar]
  • 30.Diabaté S, Chamberland A, Geraldo N, Tremblay C, Alary M. Gonorrhea, Chlamydia and HIV incidence among female sex workers in Cotonou, Benin: A longitudinal study. PloS One 2018; 13:e0197251. doi: 10.1371/journal.pone.0197251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Braunstein SL, Ingabire CM, Kestelyn E, Uwizera AU, Mwamarangwe L, Ntirushwa J, et al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis 2011; 38:385–394. doi: 10.1097/olq.0b013e31820b8eba [DOI] [PubMed] [Google Scholar]
  • 32.Scorgie F, Chersich MF, Ntaganira I, Gerbase A, Lule F, Lo Y-R. Socio-Demographic Characteristics and Behavioral Risk Factors of Female Sex Workers in Sub-Saharan Africa: A Systematic Review. AIDS Behav 2012; 16:920–933. doi: 10.1007/s10461-011-9985-z [DOI] [PubMed] [Google Scholar]
  • 33.Szwarcwald CL, Damacena GN, de Souza-Júnior PRB, Guimarães MDC, da S de Almeida W, de Souza Ferreira AP, et al. Factors associated with HIV infection among female sex workers in Brazil. Medicine (Baltimore) 2018; 97:S54–S61. doi: 10.1097/MD.0000000000009013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Muldoon KA. A systematic review of the clinical and social epidemiological research among sex workers in Uganda. BMC Public Health 2015; 15:1226. doi: 10.1186/s12889-015-2553-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Hamid Sharifi

8 Mar 2022

PONE-D-22-02895Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assaysPLOS ONE

Dear Dr. Nouaman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 22 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Hamid Sharifi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Please amend the manuscript submission data (via Edit Submission) to include author Hervé Dao.

5. One of the noted authors is a group or consortium [the ANRS 12361 PrEP-CI team]. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a well written paper on the factors that influence HIV positivity in Female Sex Workers from two different cities in Côte d’Ivoire. The factors that favor HIV infection are age of less than 24 years old, being non -Ivorian, less education, if the clients have paid less, larger number of clients on a single day, inconsistent use of condoms by the client, or condomless sex, especially if extra money has been paid for the same, and presence of STDs. They have also calculated the incidence of HIV infection per 100 person years and used RITA to determine recent HIV infections of less than six months .

The paper is well written and has nothing new to offer in terms of determination of factors favoring HIV infection in FSW. However RITA is the new factor mentioned in this paper.

Some clarifications:

1. Did all FSW have both rapid tests or only one as a screening test. This is not clear in line 174.

2. In Table 1, under duration of sex activity should it not be less than 3 years or more than 3 years . It says less than 3 years and more than 4 years. What about those between 3and 4 years . Lines 267 to 269 state only below and above 4 years . Kindly rectify.

3.Abidjan saw more sexual activity than San Pedro. Yet, San Pedro shows shows higher infection rates of Hiv. A sentence or two should be added to explain this in discussion.

4. The fact that this was a convenience sample rather than a random sample and therefore certain statistical tests could not be done should be shifted to limitations of the study. Also the fact that multivariate analysis is not available for RITA.

Reviewer #2: This is a very interesting paper on the use of HIV Recent Infection Testing Algorithm (RITA) to measure recent HIV infection and HIV incidence in a convenience sample of FSW in two towns in Côte d'Ivoire. This study will be a great addition to the literature, especially as it informs the epidemiology of HIV among key populations. I have a few questions that I hope the authors can address to strengthen the manuscript (below):

Introduction

• Can the authors explain why RITA needs to be adapted to geographic context if it is an assay that measures immunological response to HIV infection (shouldn’t this biological response not be dependent on geographic context?)?

Methods

• I appreciate the authors specifying who is the target population for this study (i.e., not all FSW). However, the authors specify that part of the target population are FSW who could potentially benefit from PrEP. Which FSW do the authors believe would not potentially benefit from PrEP in the future, given the high prevalence of HIV among FSW?

• Specifically, how was recruitment done for this study? Were FSW incentivized to participate?

• Because, as the authors admit, this is a convenience sample, I do not think it makes sense to include CIs for the HIV incidence rate, which assumes the data come from a probability distribution. Could the authors please comment?

• How is the HIV incidence calculation impacted by this being a convenience sample? Put another way, how is the HIV incidence calculation robust to this being a convenience and not a random (or otherwise probabilistic) sample?

Results

• Although results are taken from convenience samples and therefore we should be cautious about directly comparing the samples, differences in the socio-demographic composition of the two samples are striking. Are there differences in the socio-demographic characteristics in the towns themselves that could explain some of the differences in the FSW populations?

Reviewer #3: The manuscript is very well-written, and speaks to an extremely important topic for improving HIV programming. A few issues require addressing in order to strengthen conclusions and improve clarity:

1) Line 170: “Price of the pass” means what?

2) Lines 176-181: over the past several years, countries have been utilizing various assays for recent infection surveillance, with varying MDRI and FRR values. The specifics of the assay and algorithm used in this study need to be described in this section.

3) Lines 311-317: given that 64.7% (per Table 1) of participants reported having had an STI in the past 12 months, while 86.9% reported “always” using condoms, perhaps the authors should comment on the reliability of reported condom use

4) Lines 318-321: it warrants mentioning that recent infection surveillance is a powerful tool with which Cote d’Ivoire’s national HIV/AIDS program may identify geographic areas and demographic groups within which HIV transmission is ongoing. This study is an excellent example of that, and similar such explorations more broadly would lend important insight into transmission dynamics in a high-stigma environment.

5) Lines 322-327: if viral load data is not integrated into the RITA, this constitutes a major limitation of the study. Without VL data, reported recent infections may include individuals who did not disclose previously known HIV+ status, who retested having been on ART, and who are therefore misclassified. The possibility of misclassification has not been discussed in this paper and needs to be addressed. Moreover, quantifying re-testers (those who test positive on recency assays, but are actually virally suppressed because of ART) would be programmatically relevant in a highly stigmatized population and environment such as this one.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Nov 17;17(11):e0271988. doi: 10.1371/journal.pone.0271988.r002

Author response to Decision Letter 0


25 Apr 2022

To the editors of the Journal of the PLOS ONE

Abidjan, April 25th 2022

Response-to-reviewers letter and revised manuscript entitled “Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays”

Dear Editors,

This document provides point-by-point responses to the reviewers’ comments. Their comments, reproduced in italics, are followed by our responses and, finally by the additional text and changes (in bold red) to the manuscript first submitted. We thank the reviewers for their comments which have helped improve our paper.

Reviewer : 1

This is a well written paper on the factors that influence HIV positivity in Female Sex Workers from two different cities in Côte d’Ivoire. The factors that favor HIV infection are age of less than 24 years old, being non -Ivorian, less education, if the clients have paid less, larger number of clients on a single day, inconsistent use of condoms by the client, or condomless sex, especially if extra money has been paid for the same, and presence of STDs. They have also calculated the incidence of HIV infection per 100 person years and used RITA to determine recent HIV infections of less than six months .

The paper is well written and has nothing new to offer in terms of determination of factors favoring HIV infection in FSW. However RITA is the new factor mentioned in this paper.

Some clarifications:

1. Did all FSW have both rapid tests or only one as à screening test. This is not clear in line 174.

2. In Table 1, under duration of sex activity should it not be less than 3 years or more than 3 years. It says less than 3 years and more than 4 years. What about those between 3and 4 years. Lines 267 to 269 state only below and above 4 years. Kindly rectify.

3. Abidjan saw more sexual activity than San Pedro. Yet, San Pedro shows shows higher infection rates of Hiv. A sentence or two should be added to explain this in discussion.

4. The fact that this was a convenience sample rather than a random sample and therefore certain statistical tests could not be done should be shifted to limitations of the study. Also the fact that multivariate analysis is not available for RITA.

Authors’ response:

1. All study participants were tested for HIV by two rapid tests. A clarification was made in the text as follows: « HIV screening was carried out by two rapid tests (Determine®, Alere and Vikia®, bioMérieux), for all surveyed FSWs, at the sex work sites » (line 179)

2. The remark is correct. We have harmonised in the tables and in the text as follows: « >3 years or more » Vs. « 3 years or less » (table 1, 2 and lines 280-281)

3. Yes, indeed the reviewer is right. Female sex workers (FSWs) in San Pedro were more likely to be exposed to HIV than those in Abidjan. Indeed, they charged a low price for the pass, which

results in a high number of customers. They also had a lower rate of condom use and were more likely to accept sex without condoms in exchange for a large sum of money. They also reported more STIs than those in Abidjan. All these factors favour exposure to HIV infection.

The discussion section has added some elements to this effect: « The high incidence of HIV infection further evidences this among FSWs in San Pedro compared to those practising in Abidjan. In fact, they charged a lower pass price with a higher number of customers. They also had a lower rate of condom use and were more likely to accept sex without condoms in exchange for a large sum of money, and they reported more STIs than those in Abidjan. All these factors favour exposure to HIV infection ». (lines 302-307).

4. The remark is relevant. And we have completed the limitations paragraph of the study as suggested : « Yet, we have to acknowledge some limitations. Fist, as RITA is a biological assay, classification of infections as recent or not does not rely on self-reported information. Some people with long-standing HIV infection and on treatment may be misclassified as newly infected. However, these false recent cases are taken into account, as a false recent rate is applied when estimating incidence. Secondly our data suffer from a lack of power due to a relative sample size with a few number of FSW recently HIV-infected. In addition, the comparison between San Pedro and Abidjan could not been done with statistical tests because the sample was not a random sample but rather a convenience sample». Also, we have already stated in the limitations that multivariate analyses were not available for RITA. (lines 348-356)

----------------------------------------------------------------------------------------------------------------------

Reviewer: 2

This is a very interesting paper on the use of HIV Recent Infection Testing Algorithm (RITA) to measure recent HIV infection and HIV incidence in a convenience sample of FSW in two towns in Côte d'Ivoire. This study will be a great addition to the literature, especially as it informs the epidemiology of HIV among key populations. I have a few questions that I hope the authors can address to strengthen the manuscript (below):

Introduction

Can the authors explain why RITA needs to be adapted to geographic context if it is an assay that measures immunological response to HIV infection (shouldn’t this biological response not be dependent on geographic context?)?

Authors’ response:

The estimation of HIV incidence by RITA depends on two key parameters : the average duration of infection (ω) and the false recent rate (ε) and their associated uncertainties, which also quantify the share of the recent among the infected and the precision of this quantification. These parameters are directly related to population levels of HIV prevalence, which determines the proportion of infected and uninfected ; and the incidence, which determines the share of the recently infected. HIV prevalence is different in different geographical contexts, that is why we say that the RITA test must be adapted to the geographical context, i.e. here to the Ivorian context. (lines 182, 185-186)

Methods

I appreciate the authors specifying who is the target population for this study (i.e., not all FSW). However, the authors specify that part of the target population are FSW who could potentially benefit from PrEP. Which FSW do the authors believe would not potentially benefit from PrEP in the future, given the high prevalence of HIV among FSW?

Specifically, how was recruitment done for this study? Were FSW incentivized to participate?

Because, as the authors admit, this is a convenience sample, I do not think it makes sense to include CIs for the HIV incidence rate, which assumes the data come from a probability distribution. Could the authors please comment?

How is the HIV incidence calculation impacted by this being a convenience sample ? Put another way, how is the HIV incidence calculation robust to this being a convenience and not a random (or otherwise probabilistic) sample?

Authors’ response:

We thank the reviewer for this comment. Indeed, our sample is not representative of the whole of FSWs. Nevertheless, in the same study, we assessed the acceptability of offering PrEP to this population. And almost all the FSWs interviewed would accept taking PrEP if it were offered to them.

The recruitment of participants for this study was made possible by the peer educator networks of two community organizations. FSW are identified by the peer educator and they work at sites that are usually visited by them for HIV prevention/screening. Almost all of the FSW work sites were visited by the peer educator. The FSWs were recruited both in prostitution sites (brothel, beaches, hotel, bar/maquis) and in the fixed clinics dedicated to sex workers of both NGOs. The recruitment involved FSWs who had never been tested for HIV or who had previously tested negative for HIV, and who were working at a sex work site at the time of the survey, in the areas targeted by the two NGOs. There was no incentive to participate in the study. All that was required was written consent to participate. (lines 160-164).

Due to the small sample size, we believe that it is important to provide a sense of the uncertainty of our estimates, in particular to see if differences between groups are relevant or not.

Considering that multivariate analysisis not possible with RITA, we believe that 95% CI constitutes a relevant indicator of the uncertainty.

We note that the assessment of HIV incidence in this key population is rare in our context, particularly in Côte d'Ivoire where the study took place. And the use of recent infection tests is a first and could provide a basis for future studies of incidence estimates in larger samples and in other populations in Côte d'Ivoire.

Results

Although results are taken from convenience samples and therefore we should be cautious about directly comparing the samples, differences in the socio-demographic composition of the two samples are striking. Are there differences in the socio-demographic characteristics in the towns themselves that could explain some of the differences in the FSW populations ?

Authors’ response: We thank the reviewer for this comment

There are differences in socio-demographic characteristics between the two cities. Indeed, Abidjan is the economic capital of the country, in full expansion compared to San Pedro where the level of poverty, literacy or education is lower. San Pedro was in the recent past the largest slum in West Africa and most of the FSWs sites are within the perimeters of this slum. (lines 242-246).

---------------------------------------------------------------------------------------------------------------------------

Reviewer: 3

The manuscript is very well-written, and speaks to an extremely important topic for improving HIV programming. A few issues require addressing in order to strengthen conclusions and improve clarity.

1) Line 170: “Price of the pass” means what?

2) Lines 176-181: over the past several years, countries have been utilizing various assays for recent infection surveillance, with varying MDRI and FRR values. The specifics of the assay and algorithm used in this study need to be described in this section.

3) Lines 311-317: given that 64.7% (per Table 1) of participants reported having had an STI in the past 12 months, while 86.9% reported “always” using condoms, perhaps the authors should comment on the reliability of reported condom use.

4) Lines 318-321: it warrants mentioning that recent infection surveillance is a powerful tool with which Cote d’Ivoire’s national HIV/AIDS program may identify geographic areas and demographic groups within which HIV transmission is ongoing. This study is an excellent example of that, and similar such explorations more broadly would lend important insight into transmission dynamics in a high-stigma environment.

5) Lines 322-327: if viral load data is not integrated into the RITA, this constitutes a major limitation of the study. Without VL data, reported recent infections may include individuals who did not disclose previously known HIV+ status, who retested having been on ART, and who are therefore misclassified. The possibility of misclassification has not been discussed in this paper and needs to be addressed. Moreover, quantifying re-testers (those who test positive on recency assays, but are actually virally suppressed because of ART) would be programmatically relevant in a highly stigmatized population and environment such as this one.

Authors’ response: We thank the reviewer for this relevant and important remark

1) « Price of the pass » mean the price of a single sexual encounter with a client. This clarification has been made in the text. (line 174)

2) In order to be more precise, we have completed the text : See section “Assessment of HIV incidence” for more details. (lines 185-186)

3) The point is well made. Indeed, the high percentage of STIs reported in the last twelve months contrasts with the proportion of systematic condom use. This could be the effect of temporality. Indeed, STIs were reported in the last 12 months while responses on condom use during sex were related to current use, in the week or month before the survey. Also, the presence of STIs could encourage and incite the FSW to systematically wear a condom during her sex work activity. The condom would be a means of preventing possible STIs.

We have completed the discussion as follows : FSW’ responses to the question assessing condom use might refer to ‘typical use’ as opposed to specific circumstances [ref 25]. Also the difference between reported STI cases and the proportion of condom use could be the effect of temporality. Indeed, STIs were reported in the last 12 months while responses on condom use during sex were related to current use, in the week or month before the survey. (lines 331-335)

4) We have included this remark in the manuscript: “Recent infection surveillance is a powerful tool with which Cote d’Ivoire’s national HIV/AIDS program may identify geographic areas and demographic groups within which HIV transmission is ongoing. More broadly, similar explorations would lend important insight into transmission dynamics in a high-stigma environment » (lines 342-346)

5) Viral load data are taken into account by RITA tests. Indeed, there is substantial evidence that a proportion of people with long-standing HIV infection are misclassified as newly infected by currently available tests for recent HIV infection. Therefore, the false recent rate of the RITA that depend on these tests can never be considered as zero. The false recent rate takes into account one or more of the following characteristics :

- Advanced infection, defined by a diagnosis of AIDS or a low CD4+ T cell count ;

- Ongoing antiretroviral treatment ;

- « Elite controllers » who have a low or undetectable viral load (World Health Organization, editor. When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva, Switzerland: World Health Organization; 2011)

The formula for calculating HIV incidence based on the results of a RITA therefore incorporates the false recent rate of the RITA into the incidence calculation. It is necessary to ensure that the false recent rate applied is relevant to the RITA and to the population for which the impact is estimated. This is why in our study we used the false recent rate from a sample of the Ivorian population.

A sentence was added in the discussion : « As RITA is a biological assay, classification of infections as recent or not does not rely on self-reported information. Some people with long-standing HIV infection and on treatment may be misclassified as newly infected. However, these false recent cases are taken into account, as a false recent rate is applied when estimating incidence”. (lines 348-352)

Attachment

Submitted filename: Response_to_reviewer_PLOS ONE_2022-04-25.docx

Decision Letter 1

Hamid Sharifi

26 May 2022

PONE-D-22-02895R1Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assaysPLOS ONE

Dear Dr. N Marcellin Nouaman

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Dear Authors

Thanks so much for submitting the revised file to PLOS ONE.

The reviewers reviewed the revised file and they put a few more comments. Please revise the file based on the reviewers' comments.

==============================

Please submit your revised manuscript by Jul 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Hamid Sharifi

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The data availability has restricted access and is not freely available .

the manuscript needs to be edited - Table 1 and Table 2 -should state - 3 years or less and more than 3 years . no need to put more symbol as well as as state more. lines 158, 303, 308, 330, 348 need to be corrected

Reviewer #2: The authors have been responsive to reviewer comments made by myself and the other reviewers. I am mostly satisfied, however, I still strongly believe that it is inappropriate to provide confidence intervals for the HIV incidence rates because the data they are using comes from a convenience sample (not a probability-based sample). Formulas to calculate confidence intervals assume some kind of probability-based sample. I appreciate that the authors want to communicate a sense of uncertainty in their estimates but what is the benefit if the confidence intervals themselves are wrong and therefore ultimately uninformative? At the very least, this must be acknowledged in the limitations; although I think it would be more appropriate to remove the confidence intervals altogether (and explain why they are not included) or do a bootstrapping technique to estimate confidence intervals.

Reviewer #3: Thank you to the authors, once again, for this excellent manuscript. One of the initial questions was not addressed:

2)Lines 176-181: over the past several years, countries have been utilizing various

assays for recent infection surveillance, with varying MDRI and FRR values. The

specifics of the assay and algorithm used in this study need to be described in this

section.

In response to this question, the authors' response was:

2)In order to be more precise, we have completed the text : See section “Assessment

of HIV incidence” for more details. (lines 185-186)

However, the question was about the specifics of the recency assay utilized. The manuscript states (lines 179-182): "Then, a dried blood spot (DBS) sample was taken and transported to the laboratory of the University Hospital of Tours, France, to determine the window of infection (0.3 years) and false positive rate (13%) using a recent infection test adapted to the Ivorian context [24] and performed directly on plasma."

Are there no additional details available regarding this assay? What is "a recent infection test adapted to the Ivorian context?" Is it a LAg-EIA? There are at least 10 different HIV recency assays currently and commercially available. Can the authors not shed any additional light on the assay that was utilized at University Hospital of Tours, akin to the specifics provided for the initial HIV rapid testing?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Nov 17;17(11):e0271988. doi: 10.1371/journal.pone.0271988.r004

Author response to Decision Letter 1


4 Jul 2022

To the editors of the Journal of the PLOS ONE

Abidjan, June 28th 2022

Response-to-reviewers letter and revised manuscript entitled “Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays”

Dear Editors,

This document provides point-by-point responses to the reviewers’ comments. Their comments, reproduced in italics, are followed by our responses and, finally by the additional text and changes to the manuscript second submitted. We thank the reviewers for their comments which have helped improve our paper.

Reviewer : 1

The data availability has restricted access and is not freely available.

The manuscript needs to be edited - Table 1 and Table 2 -should state - 3 years or less and more than 3 years . No need to put more symbol as well as as state more. lines 158, 303, 308, 330, 348 need to be corrected

Authors’ response:

We thank the reviewer for this comment. The data are available on Zenodo.org, with the following link https://zenodo.org/record/5948841. Access to the data is available on request on the website Zenodo.org. We mentioned this in the manuscript (line 212). In addition, we have attached in this new revision of the manuscript, the scripts and the analysis reports.

Also, we have corrected tables 1 and 2 by removing the symbol at the level of 3 years or less and more than 3 which was unnecessary. Corrections have also been made to the lines 286, 287, 297, 300.

----------------------------------------------------------------------------------------------------------------------

Reviewer : 2

The authors have been responsive to reviewer comments made by myself and the other reviewers. I am mostly satisfied, however, I still strongly believe that it is inappropriate to provide confidence intervals for the HIV incidence rates because the data they are using comes from a convenience sample (not a probability-based sample). Formulas to calculate confidence intervals assume some kind of probability-based sample. I appreciate that the authors want to communicate a sense of uncertainty in their estimates but what is the benefit if the confidence intervals themselves are wrong and therefore ultimately uninformative ? At the very least, this must be acknowledged in the limitations ; although I think it would be more appropriate to remove the confidence intervals altogether (and explain why they are not included) or do a bootstrapping technique to estimate confidence intervals.

Authors’ response: We thank the reviewer for this relevant and important remark. Indeed, confidence intervals provide for the HIV incidence rates are inappropriate because our data become from a convenience sample. In order to find a more appropriate solution, we used a bootstrapping technique to estimate our confidence intervals as suggested by the reviewer. These confidence intervals were very wide, so we decided to remove them on the differents estimated incidences (see table 2) and we have mentioned this in the limitations of the study (lines 374 – 375).

We have attached in this new revision of the manuscript, the scripts and the analysis reports for details.

---------------------------------------------------------------------------------------------------------------------------

Reviewer : 3

Thank you to the authors, once again, for this excellent manuscript. One of the initial questions was not addressed:

2) Lines 176-181: over the past several years, countries have been utilizing various assays for recent infection surveillance, with varying MDRI and FRR values. The specifics of the assay and algorithm used in this study need to be described in this section.

In response to this question, the authors' response was:

2)In order to be more precise, we have completed the text : See section “Assessment of HIV incidence” for more details. (lines 185-186)

However, the question was about the specifics of the recency assay utilized. The manuscript states (lines 179-182): "Then, a dried blood spot (DBS) sample was taken and transported to the laboratory of the University Hospital of Tours, France, to determine the window of infection (0.3 years) and false positive rate (13%) using a recent infection test adapted to the Ivorian context [24] and performed directly on plasma."

Are there no additional details available regarding this assay ? What is "a recent infection test adapted to the Ivorian context ?" Is it a LAg-EIA ? There are at least 10 different HIV recency assays currently and commercially available. Can the authors not shed any additional light on the assay that was utilized at University Hospital of Tours, akin to the specifics provided for the initial HIV rapid testing?

Authors’ response: We thank the reviewer for this relevant and important remark

We have given further details by describing the principle of carrying out this test as follows :

This recent infection test developed by Barin et al. is the Less-sensitive enzyme Immunodominant assay recent infection (EIA-RI/IDE-V3). This assay uses the enzyme immunoassay technique in a 96-well plate, based on the measurement of absorbances (OD) in one well sensitised with an equimolar peptide mixture TM (cons+D), corresponding to the immunodominant epitope of gp41 (consensus sequence envi - 1 group M and consensus sequence env - 1 subtype D), and in another well, sensitised with a V3 peptide solution (AE), corresponding to an equimolar mixture of the consensus sequences of the V3 region of gp120 of the HIV subtypes A, B, C, D and CRF01_AE. This test is an in-house test, applicable in the HIV-NRC virology laboratory, serology sector. The test can be performed on serum or plasma, as well as serum, plasma or whole blood on blotting paper or dried blood spots. The test uses a mathematical formula that combines the quantitative responses to gp41 antigens in each region to distinguish between recent and established infection.

This in-house test has been the subject of preliminary studies using sequential serum samples from HIV-infected Ivorian patients with known dates of infection (the PRECO-CI ANRS 12277 and PRIMO-CI ANRS 1220 projects) and samples from patients at different stages of the disease (the Temprano ANRS 12136 and Trivacan ANRS 1269 trials) ; which allowed to distinguish a recent infection (≤180 days) from an established infection (>180 days) with a window of infection (0.3 years) and false positive rate (13‰) for the Ivorian population studied.

We have thus completed the paragraph “HIV screening and laboratory” in the manuscript (lines 185 - 202)

Attachment

Submitted filename: Response_to_reviewer_PLOS ONE_2022-06-30.docx

Decision Letter 2

Hamid Sharifi

12 Jul 2022

Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays

PONE-D-22-02895R2

Dear Dr. N Marcellin Nouaman

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Hamid Sharifi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Hamid Sharifi

8 Nov 2022

PONE-D-22-02895R2

Incidence of HIV infection and associated factors among female sex workers in Côte d’Ivoire, results of the ANRS 12361 PrEP-CI study using recent infection assays

Dear Dr. Nouaman:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Hamid Sharifi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (ZIP)

    Attachment

    Submitted filename: Response_to_reviewer_PLOS ONE_2022-04-25.docx

    Attachment

    Submitted filename: Response_to_reviewer_PLOS ONE_2022-06-30.docx

    Data Availability Statement

    For ethical reasons, the full survey dataset is available only upon reasonable request at https://zenodo.org/record/5948841. An analytical dataset containing only the variables required to replicate the analysis, as well as the corresponding R script, are available in Supplementary material.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES